Vivid Dx
Vivid Dx is an Oxford, UK-based provider of a precision diagnostics platform improving pathogen detection and antimicrobial resistance (AMR) testing.
Vivid Dx has raised €13M across 1 funding round from 4 investors, most recently a Seed round in Jul 2026. Based in Oxford, UK; active in Healthtech. Data as of 28 Oct 2026.
Oxford, UKvivid-dx.com ↗
Total raised
€13M
€13,181,019
Funding rounds
1
Investors
4
distinct backers
Active since
2026-07
latest 2026-07
Funding by year
EUR raised per year · 2026 YTDVivid Dx — funding by year — interactive chart.
Data table
| Vivid Dx — funding by year | |
|---|---|
| 2026 | €13M |
Signals
High confidenceRaise-next likelihood25
base rate 44% for Seed
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-07-29 | Seed | €13M | Cedars-Sinai Intellectual Property Co.,Jameel Investment Management Company,other investors,Oxford Science Enterprises | View deal → |